Related Experiment Video
Updated: Apr 1, 2026
09:03
Manufacture and Drug Delivery Applications of Silk Nanoparticles
Published on: October 8, 2016
16.8K
PEGylated Silk Nanoparticles for Anticancer Drug Delivery
Thidarat Wongpinyochit1, Petra Uhlmann2, Andrew J Urquhart3
1Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde , 161 Cathedral Street, Glasgow, G4 0RE, United Kingdom.
Biomacromolecules
|September 30, 2015
Summary
PEGylated silk nanoparticles show promise as an anticancer drug delivery system. These novel nanomedicines demonstrate high drug loading, controlled release, and significant cytotoxicity against breast cancer cells.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery
Background:
- Silk is a clinically validated biopolymer with potential in nanomedicine.
- Silk-based nanomedicines require "stealth" modifications for enhanced efficacy.
- Polyethylene glycol (PEG)ylation is a key strategy for improving nanomedicine performance.
Purpose of the Study:
- To develop and evaluate PEGylated silk nanoparticles for targeted anticancer drug delivery.
- To assess the physicochemical properties, drug loading, and release kinetics of these nanoparticles.
- To investigate the in vitro cytotoxicity of drug-loaded PEGylated silk nanoparticles against human breast cancer cells.
Main Methods:
- Fabrication of silk nanoparticles from B. mori silk using nanoprecipitation.
- Surface modification of silk nanoparticles with polyethylene glycol (PEG).
- Characterization of nanoparticle size, zeta potential, morphology, stability, drug encapsulation efficiency, and pH-dependent drug release.
Main Results:
- PEGylated silk nanoparticles exhibited optimal size (104 ± 1.7 nm) and stability.
- High encapsulation efficiency (>93%) was achieved for anticancer drugs.
- pH-dependent drug release over 14 days and significant cytotoxicity against human breast cancer cells were demonstrated.
Conclusions:
- PEGylated silk nanoparticles represent a promising platform for anticancer nanomedicine.
- The "stealth" properties imparted by PEG enhance the potential of silk-based drug delivery systems.
- This study supports the advancement of silk nanoparticles in clinical oncology applications.
